HYDROCORTISONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Hydrocortisone Acetate patents expire, and what generic alternatives are available?
Hydrocortisone Acetate is a drug marketed by Cenci, Imperium, Parke Davis, Purepac Pharm, Bel Mar, Epic Pharma Llc, Watson Labs, Fera Pharms, X Gen Pharms, and Genus. and is included in thirteen NDAs.
The generic ingredient in HYDROCORTISONE ACETATE is hydrocortisone acetate; pramoxine hydrochloride. There are sixty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate; pramoxine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCORTISONE ACETATE?
- What are the global sales for HYDROCORTISONE ACETATE?
- What is Average Wholesale Price for HYDROCORTISONE ACETATE?
Summary for HYDROCORTISONE ACETATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 20 |
| Patent Applications: | 3,835 |
| Drug Prices: | Drug price information for HYDROCORTISONE ACETATE |
| DailyMed Link: | HYDROCORTISONE ACETATE at DailyMed |
Recent Clinical Trials for HYDROCORTISONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Orion Corporation, Orion Pharma | Phase 1 |
| Merck Sharp & Dohme LLC | Phase 1 |
| University Medical Center Groningen | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCORTISONE ACETATE
US Patents and Regulatory Information for HYDROCORTISONE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | HYDROCORTISONE ACETATE | hydrocortisone acetate | CREAM;TOPICAL | 080419-001 | Jan 25, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bel Mar | HYDROCORTISONE ACETATE | hydrocortisone acetate | INJECTABLE;INJECTION | 083739-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Purepac Pharm | HYDROCORTISONE ACETATE | hydrocortisone acetate | CREAM;TOPICAL | 086050-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROCORTISONE ACETATE | hydrocortisone acetate | INJECTABLE;INJECTION | 083759-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | HYDROCORTISONE ACETATE | hydrocortisone acetate | INJECTABLE;INJECTION | 009637-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
